Next-gen sequencing leader joins microprocessing giant to apply genomics and AI technologies toward drug discovery, clinical research, and human health SAN FRANCISCO—Nvidia will partner with Illumina to apply genomics and AI technologies to analyze and interpret multi-omic data in drug discovery, clinical research, and human health, the companies said in a collaboration of technology leaders […]
The post Illumina, Nvidia Launch AI-Based Genomics Partnership first appeared on Tissuepathology.com.↧